Ares Capital Corporation:企業のM&A・事業提携・投資動向

◆英語タイトル:Ares Capital Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1411
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:101
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Ares Capital Corporation – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Ares Capital Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Ares Capital Corporation since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Ares Capital Corporation’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Ares Capital Corporation. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Ares Capital Corporation’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Ares Capital Corporation and its subsidiaries since 2007.
- Information about key financial and legal advisors for Ares Capital Corporation’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Ares Capital Corporation’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Overview 9
Mergers and Acquisitions – Deal reports 10
CORPORATE VENTURING 21
Corporate Venturing – Overview 21
Corporate Venturing – Deal reports 22
PARTNERSHIP 33
Partnership – Overview 33
Partnership – Deal reports 34
CAPITAL RAISING 37
Capital Raising – Overview 37
Capital Raising – Deal reports 38
DIVESTMENTS 73
Divestments – Overview 73
Divestments – Deal reports 74
APPENDIX 91
Contact Us 91
About MarketLine Financial Deals Database 91
Deal Definition and Methodology 93
About MarketLine 100

List of Tables
Table 1: Ares Capital Corporation M&A volume and value trend (2014-YTD2018)
Table 2: Ares Capital Corporation M&A activity by geography (2014-YTD2018)
Table 3: Ares Capital Corporation corporate venturing volume and value trend (2014-YTD2018)
Table 4: Ares Capital Corporation corporate venturing by geography (2014-YTD2018)
Table 5: Ares Capital Corporation partnership volume and value trend (2014-YTD2018)
Table 6: Ares Capital Corporation partnership trend by key deal type (2014-YTD2018)
Table 7: Ares Capital Corporation capital raising volume and value trend (2014-YTD2018)
Table 8: Ares Capital Corporation capital raising by deal type (2014-YTD2018)
Table 9: Ares Capital Corporation divestments volume and value trend (2014-YTD2018)
Table 10: Ares Capital Corporation divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Ares Capital Corporation M&A volume and value trend (2014-YTD2018)
Figure 2: Ares Capital Corporation M&A activity by geography (2014-YTD2018)
Figure 3: Ares Capital Corporation corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Ares Capital Corporation corporate venturing by geography (2014-YTD2018)
Figure 5: Ares Capital Corporation partnership volume and value trend (2014-YTD2018)
Figure 6: Ares Capital Corporation partnership trend by key deal type (2014-YTD2018)
Figure 7: Ares Capital Corporation capital raising volume and value trend (2014-YTD2018)
Figure 8: Ares Capital Corporation capital raising by deal type (2014-YTD2018)
Figure 9: Ares Capital Corporation divestments volume and value trend (2014-YTD2018)
Figure 10: Ares Capital Corporation divestments by geography (2014-YTD2018)

★海外企業調査レポート[Ares Capital Corporation:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cimentos de Portugal SGPS SA:企業の戦略的SWOT分析
    Cimentos de Portugal SGPS SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Anthem Inc (ANTM):企業の財務・戦略的SWOT分析
    Anthem Inc (ANTM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Tata Motors Limited:企業の戦略・SWOT・財務情報
    Tata Motors Limited - Strategy, SWOT and Corporate Finance Report Summary Tata Motors Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Samyang Biopharmaceuticals Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Samyang Biopharmaceuticals Corp (Samyang Biopharm) researches and develops technology platforms for drug delivery. Its product portfolio comprises transdermal patches, injections, ORC hemostat and others. The company spans its expertise in the development and distribution of biodegradable, s …
  • ABIONYX Pharma SA (CEREN):企業の財務・戦略的SWOT分析
    Summary ABIONYX Pharma SA (ABIONYX) is a biopharmaceutical company that discovers and develops HDL therapies for the treatment of cardiovascular and metabolic diseases. Its therapies include CER-001 a negatively-charged lipoprotein particle that find application in atheosclerotic plaque regression; …
  • MannKind Corp (MNKD)-医療機器分野:企業M&A・提携分析
    Summary MannKind Corp (MannKind) is a biopharmaceutical company that discovers, develops and commercializes therapeutic products to treat diseases such as diabetes. The company’s lead product, Afrezza is a rapid-acting, inhaled insulin used to control high blood sugar in adults with type 1 and type …
  • TUI Group:企業の戦略・SWOT・財務分析
    TUI Group - Strategy, SWOT and Corporate Finance Report Summary TUI Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • MeVis Medical Solutions AG (M3V):企業の財務・戦略的SWOT分析
    MeVis Medical Solutions AG (M3V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • BioCardia Inc:製品パイプライン分析
    Summary BioCardia Inc (BioCardia) is a clinical-stage regenerative medicine company that develops novel therapeutics for cardiovascular diseases. The company develops biotherapeutic candidate, which include CardiAMP cell therapy system, an autologous minimally processed bone marrow cells; and CardiA …
  • Sahara Energy Ltd (SAH):石油・ガス:M&Aディール及び事業提携情報
    Summary Sahara Energy Ltd (Sahara Energy) is an oil and gas exploration and development company that acquires, exploits, explores, and develops oil and natural gas reserves in Western Canada. The company evaluates oil and gas exploration properties in Canada. It plans on growing through the drill bi …
  • Metalfrio Solutions SA:企業の戦略・SWOT・財務情報
    Metalfrio Solutions SA - Strategy, SWOT and Corporate Finance Report Summary Metalfrio Solutions SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Euro India Fresh Foods, Ltd. (EIFFL):企業の財務・戦略的SWOT分析
    Euro India Fresh Foods, Ltd. (EIFFL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Luitpold Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Luitpold Pharmaceuticals Inc (Luitpold Pharmaceuticals), a subsidiary of Daiichi Sankyo Co Ltd is a manufacturer and marketer of drugs and medical devices. The company provides products such as injectable parenteral medications that are used in pharmacy admixtures and nutrient solutions, cri …
  • Olympus Corporation (7733)-医療機器分野:企業M&A・提携分析
    Summary Olympus Corporation (Olympus) is a manufacturer of precision machineries and instruments. The company develops, manufactures and markets equipment and devices for medical, healthcare, imaging, information, and other industrial markets. It offers a wide range of products including digital SLR …
  • HemaCare Corp (HEMA):企業の財務・戦略的SWOT分析
    Summary HemaCare Corp (HemaCare) is a provider of biological blood products and services. The company offers primary blood cells and tissues derived from normal and mobilized peripheral blood, cord blood, and bone marrow. It spans its expertise in isolations, custom cell collections and testing of p …
  • Spineway SAS (ALSPW):企業の財務・戦略的SWOT分析
    Summary Spineway SAS (Spineway) is a medical device company that manufactures, designs, and commercializes surgical implants and instruments. The company offers products such as thoraco-lumbar, cervical, mini invasive products and other bio materials. Its thoraco-lumbar products include mont blanc d …
  • OncoSec Medical Inc (ONCS):企業の財務・戦略的SWOT分析
    Summary OncoSec Medical Inc (OncoSec) is a biotechnology company. The company offers services to stimulate body’s immune system and attack cancer. Its lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor th …
  • Dairy Crest Group plc:戦略・SWOT・企業財務分析
    Dairy Crest Group plc - Strategy, SWOT and Corporate Finance Report Summary Dairy Crest Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Virgin Australia Holdings Limited:企業のM&A・事業提携・投資動向
    Virgin Australia Holdings Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Virgin Australia Holdings Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • La Jolla Pharmaceutical Company (LJPC):製薬・医療:M&Aディール及び事業提携情報
    Summary La Jolla Pharmaceutical Company (La Jolla) is a biopharmaceutical company that discovers, develops and commercializes pharmaceutical products for life threatening diseases. The company’s major product includes Giapreza, an injection for intravenous infusion indicated to increase blood pressu …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆